Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Cash from Operations (2018 - 2025)

Historic Cash from Operations for AdaptHealth (AHCO) over the last 8 years, with Q3 2025 value amounting to $161.1 million.

  • AdaptHealth's Cash from Operations rose 1153.77% to $161.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $569.0 million, marking a year-over-year increase of 408.13%. This contributed to the annual value of $541.8 million for FY2024, which is 1272.67% up from last year.
  • As of Q3 2025, AdaptHealth's Cash from Operations stood at $161.1 million, which was up 1153.77% from $162.0 million recorded in Q2 2025.
  • In the past 5 years, AdaptHealth's Cash from Operations ranged from a high of $198.0 million in Q2 2024 and a low of $18.4 million during Q1 2021
  • In the last 5 years, AdaptHealth's Cash from Operations had a median value of $103.5 million in 2022 and averaged $110.0 million.
  • In the last 5 years, AdaptHealth's Cash from Operations surged by 29454.03% in 2022 and then plummeted by 6503.69% in 2024.
  • Quarter analysis of 5 years shows AdaptHealth's Cash from Operations stood at $100.9 million in 2021, then fell by 3.97% to $96.9 million in 2022, then surged by 60.2% to $155.3 million in 2023, then decreased by 3.12% to $150.4 million in 2024, then grew by 7.08% to $161.1 million in 2025.
  • Its Cash from Operations stands at $161.1 million for Q3 2025, versus $162.0 million for Q2 2025 and $95.5 million for Q1 2025.